SCHEMBL988022

SCHEMBL988022

COc1cc(C(=O)Cl)cc(Cl)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.47
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA3 P07451 1/20 0.41
PKM P14618 1/20 0.41
CA5A P35218 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL987150 0.90 LMNA (0.45) ALDH1A1HPGDCA12CA1CA2
SCHEMBL4907208 0.85 CA12 (0.60) ALDH1A1HPGDCA12CA1CA2
SCHEMBL27189692 0.83 ALDH1A1 (0.68) ALDH1A1HPGDCYP1A2CYP3A4TSHR
SCHEMBL30822595 0.83 ALDH1A1 (0.68) ALDH1A1HPGDCYP1A2CYP3A4TSHR
SCHEMBL4898203 0.83 MEN1 (0.55) ALDH1A1HPGDCA12CA1CA2
SCHEMBL1457782 0.83 ALDH1A1 (0.50) ALDH1A1HPGDCA12CA1CA2
SCHEMBL30927157 0.83 ALDH1A1 (0.50) ALDH1A1HPGDCA12CA1CA2
SCHEMBL20873369 0.81 BPTF (0.42) ALDH1A1HPGDCA12CA1CA2
SCHEMBL983196 0.79 HPGD (0.46) ALDH1A1HPGDCYP3A4TSHRTPMT
SCHEMBL985523 0.78 ALDH1A1 (0.61) ALDH1A1HPGDLMNATPMTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed
US-4003927-A DIURETICS MERCK & CO., INC. (US) 1977-01-18 US disclosed